Blueprint Medicines
Business Services · Massachusetts, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
45 Sidney St Fl 5, Cambridge, Massachuse...Phone Number
(617) 374-7580Website
www.blueprintmedicines.comRevenue
$562.1 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
4
5
5
2
2
2
About Blueprint Medicines
Blueprint Medicines was founded in 2008. This company provides the research and development of new medicines to improve the lives of patients with genomically defined diseases. Their headquarters are located in Cambridge, Massachusetts.Explore more
Blueprint Medicines Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Blueprint Medicines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Blueprint Medicines
Product Launch: Get notified when Blueprint Medicines launches new products
Click to see if Blueprint Medicines had a recent Job posting/layoffs
Blueprint Medicines, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Blueprint Medicines has new funding data
Earning: See what the market has to say on Blueprint Medicines recently announced quarterly report
Check if Blueprint Medicines has recently received funding, and reach out quickly before it becomes old news!
Check out if Blueprint Medicines is spiking on competitors!
Recommended Actions
Find VP level buyers at Blueprint Medicines
Find 3 more new buyers
Compare Similar Companies to Blueprint Medicines
Compare insights from companies similar to Blueprint Medicines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$408.5M
1K - 5K
Private
$921.8M
2006
SR
Shana RossSenior Vice President and Chief Human Resources Officer
Company Profile Activity
Activity Insights
Blueprint Medicines is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Blueprint Medicines is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Blueprint Medicines.
Blueprint Medicines financials insights
Gather financial insights about Blueprint Medicines, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Series A
$40M
2014
Series B
$25M
Series C
$50M
2015
Stock Offering
$168.6M
2016
Stock Offering
$134.5M
2019
Stock Offering
$327.2M
2022
Other Financing Round
$1.3B
Blueprint Medicines Tech Stack
A closer look at the technologies used by Blueprint Medicines
See more technologies
Most Recent Scoops
Person-Based
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Left Company
Executive Move
Executive Moves, Left Company
Project
Contracts
Project
Laboratory Operations, Medical Research, Clinical Operations
Blueprint Medicines News & Media
Blueprint Medicines, a Sanofi Company, Highlights Long-Term Clinical Benefit of AYVAKIT® (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting
-- Durable disease control and quality-of-life improvements for patients with ISM in the PIONEER trial -- -- Prolonged survival, including in the first-line treatment setting, for patients with advanced SM in the PATHFINDER trial -- CAMBRIDGE, Mass., Dec. 5, 2025 /PRNewswire/ -- Blueprint...Press Release: Sanofi completes acquisition of Blueprint Medicines
Sanofi completes acquisition of Blueprint MedicinesPress Release: Sanofi announces extension of Blueprint tender offer
Sanofi announces extension of Blueprint tender offer$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Blueprint Medicines Corporation (NASDAQ: BPMC)
NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Blueprint Medicines Corporation (NASDAQ: BPMC) related to its sale to Sanofi, S.A. Under the terms
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Blueprint Medicines
Sign Up For FreeTo access detailed company insights
Blueprint Medicines was founded in 2008. This company provides the research and development of new medicines to improve the lives of patients with genomically defined diseases. Their headquarters are located in Cambridge, Massachusetts.... Read More
